Merck Announces VAXNEUVANCE Met Key Immunogenicity and Safety Endpoints in Phase 3 Pivotal Trial Evaluating Use in Infants, PNEU-PED Pharmaceutical Investing
Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine Medical Device Investing
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Trillium Therapeutics Inc. Biotech Investing
Ovarian Cancer Victims Ask Court to Block Johnson & Johnson's 'Texas Two-Step' Bankruptcy Plan Medical Device Investing
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Trillium Therapeutics, Inc. Buyout Biotech Investing
TRILLIUM ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of TRIL and Encourages Investors to Contact the Firm Biotech Investing
Medtronic Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis Medical Device Investing
Danaher Announces Human Resources And Accounting Leadership Transition Plans Medical Device Investing
European Commission Approves RINVOQ® as First JAK Inhibitor in the European Union for the Treatment of Both Adults and Adolescents with Moderate to Severe Atopic Dermatitis Biotech Investing
Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug Application for Phase II Clinical Trial of CardiolRx for Acute Myocarditis Biotech Investing
